Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 318 | $279,172,486 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 Jan 2024 16:17 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 02 Jan 2024 | Sale | 274 | 873.91 | 239,451 | D |
04 Jan 2024 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | ZOGHBI HUDA Y | Director | 02 Jan 2024 | Sale | 1,117 | 900 | 1,005,300 | D |
04 Jan 2024 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 03 Jan 2024 | Sale | 826 | 914 | 754,964 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 3 | 904.49 | 2,713 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 13 | 903.49 | 11,745 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 10 | 902.37 | 9,024 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 9 | 901.46 | 8,113 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 29 | 900.59 | 26,117 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 14 | 899.66 | 12,595 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 6 | 898.76 | 5,393 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 3 | 897.41 | 2,692 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 8 | 896.47 | 7,172 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 1 | 892 | 892 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 1 | 887.13 | 887 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 2 | 886.26 | 1,773 | D |
04 Jan 2024 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 Jan 2024 | Sale | 1 | 873.91 | 874 | D |
29 Dec 2023 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 27 Dec 2023 | Sale | 2,448 | 856.71 | 2,097,226 | D |
29 Dec 2023 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | BROWN MICHAEL S | Director | 27 Dec 2023 | Sale | 2,049 | 898 | 1,840,002 | D |
26 Dec 2023 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 22 Dec 2023 | Sale | 250 | 846.27 | 211,568 | D |
26 Dec 2023 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 21 Dec 2023 | Sale | 1,224 | 844.09 | 1,033,166 | D |
26 Dec 2023 16:08 | REGN | REGENERON PHARMACEUTICALS Inc | FENIMORE CHRISTOPHER R. | SVP Controller | 21 Dec 2023 | Sale | 456 | 843.79 | 384,768 | D |
14 Dec 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 13 Dec 2023 | Sale | 610 | 870 | 530,700 | D |
12 Dec 2023 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 11 Dec 2023 | Sale | 270 | 838.44 | 226,379 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 184 | 821.46 | 151,149 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 345 | 820.54 | 283,086 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 973 | 819.57 | 797,442 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 1,333 | 818.59 | 1,091,180 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 1,881 | 817.36 | 1,537,454 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 829 | 816.46 | 676,845 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 58 | 814.06 | 47,215 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 155 | 815.97 | 126,475 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 167 | 813.66 | 135,881 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 372 | 812.57 | 302,276 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 103 | 811.37 | 83,571 | D |
06 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 05 Dec 2023 | Sale | 136 | 810.38 | 110,212 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 10 | 826.62 | 8,266 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 2 | 827.61 | 1,655 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 2 | 825.38 | 1,651 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 3 | 824.66 | 2,474 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 6 | 823.36 | 4,940 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 2 | 821.92 | 1,644 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 1 | 822.49 | 822 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 9 | 820.5 | 7,384 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 7 | 819.62 | 5,737 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 2 | 818.76 | 1,638 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 6 | 817.52 | 4,905 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 4 | 816.52 | 3,266 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 3 | 815.46 | 2,446 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 1 | 814.78 | 815 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 4 | 813.35 | 3,253 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 3 | 812.58 | 2,438 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 27 | 811.48 | 21,910 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 7 | 810.77 | 5,675 | D |
04 Dec 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 01 Dec 2023 | Sale | 1 | 809.03 | 809 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 19 | 805 | 15,295 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 19 | 804.89 | 15,293 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 330 | 803.38 | 265,115 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 347 | 802.63 | 278,513 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 382 | 800.55 | 305,810 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 877 | 801.56 | 702,968 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 1,601 | 799.48 | 1,279,967 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 1,614 | 798.63 | 1,288,989 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 204 | 797.79 | 162,749 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 347 | 795.38 | 275,997 | D |
15 Nov 2023 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 14 Nov 2023 | Sale | 752 | 794.57 | 597,517 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 1 | 838.46 | 838 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 3 | 830.39 | 2,491 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 18 | 829.43 | 14,930 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 39 | 828.54 | 32,313 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 11 | 827.65 | 9,104 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 4 | 826.58 | 3,306 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 18 | 825.53 | 14,860 | D |
08 Nov 2023 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 07 Nov 2023 | Sale | 6 | 824.59 | 4,948 | D |
02 Nov 2023 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Nov 2023 | Sale | 1,000 | 783.91 | 783,910 | D |
17 Oct 2023 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | ZOGHBI HUDA Y | Director | 13 Oct 2023 | Sale | 1,000 | 850 | 850,000 | D |
03 Oct 2023 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 02 Oct 2023 | Sale | 1,038 | 827 | 858,426 | D |
22 May 2024 16:02 | REGN | REGENERON PHARMACEUTICALS Inc | LAROSA JOSEPH J | EVP General Counsel and Secret | 21 May 2024 | Sale | 1,865 | 994.9 | 1,855,488 | D |
17 May 2024 17:57 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 17 May 2024 | Sale | 143 | 980.07 | 140,150 | D |
17 May 2024 17:57 | REGN | REGENERON PHARMACEUTICALS Inc | SCHLEIFER LEONARD S | Bd. Co-Chair, President & CEO | 17 May 2024 | Sale | 22,687 | 979.22 | 22,215,564 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 120 | 989.14 | 118,697 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 373 | 988.36 | 368,658 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 182 | 987.38 | 179,703 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 442 | 986.4 | 435,989 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 647 | 985.62 | 637,696 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 53 | 984.02 | 52,153 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 727 | 983.88 | 715,281 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 303 | 982.29 | 297,634 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 2,283 | 981.52 | 2,240,810 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,223 | 980.72 | 1,199,421 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 504 | 979.87 | 493,854 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 4,865 | 978.44 | 4,760,111 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 9,851 | 977.42 | 9,628,564 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 5,225 | 975.6 | 5,097,510 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 6,885 | 976.56 | 6,723,616 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 4,778 | 974.47 | 4,656,018 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,865 | 973.43 | 1,815,447 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 784 | 972.5 | 762,440 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 846 | 970.36 | 820,925 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 406 | 971.28 | 394,340 | D |
17 May 2024 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | YANCOPOULOS GEORGE | Bd. Co-Chair, President & CSO | 15 May 2024 | Sale | 1,930 | 969.14 | 1,870,440 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)